As expected, immune cells expressing the common leucocyte antigen (CD45) were prevalent within the BCC (13.11% ± 2.88% [n = 14]) and SCC (14.42% ± 1.73% ([n = 26]) TME (Figure 1A), consistent with antitumor immunity (Figure 1B). The gene discussed is PTPRC; the disease is skin basal cell carcinoma.